Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2013

01-11-2013 | Original Research

A Randomized Trial of Treatments for High-Utilizing Somatizing Patients

Authors: Arthur J. Barsky, MD, David K. Ahern, PhD, Mark R. Bauer, MD, Nyryan Nolido, MA, E. John Orav, PhD

Published in: Journal of General Internal Medicine | Issue 11/2013

Login to get access

ABSTRACT

BACKGROUND

Somatization and hypochondriacal health anxiety are common sources of distress, impairment, and costly medical utilization in primary care practice. A range of interventions is needed to improve the care of these patients.

OBJECTIVE

To determine the effectiveness of two cognitive behavioral interventions for high-utilizing, somatizing patients, using the resources found in a routine care setting.

DESIGN

Patients were randomly assigned to a two-step cognitive behavioral treatment program accompanied by a training seminar for their primary care physicians, or to relaxation training. Providers routinely working in these patients’ primary care practices delivered the cognitive behavior therapy and relaxation training. A follow-up assessment was completed immediately prior to treatment and 6 and 12 months later.

SUBJECTS

Eighty-nine medical outpatients with elevated levels of somatization, hypochondriacal health anxiety, and medical care utilization.

MEASUREMENTS

Somatization and hypochondriasis, overall psychiatric distress, and role impairment were assessed with well-validated, self-report questionnaires. Outpatient visits and medical care costs before and after the intervention were obtained from the encounter claims database.

RESULTS

At 6 month and 12 month follow-up, both intervention groups showed significant improvements in somatization (p < 0.01), hypochondriacal symptoms (p < 0.01), overall psychiatric distress (p < 0.01), and role impairment (p < 0.01). Outcomes did not differ significantly between the two groups. When both groups were combined, ambulatory visits declined from 10.3 to 8.8 (p = 0.036), and mean ambulatory costs decreased from $3,574 to $2,991 (p = 0.028) in the year preceding versus the year following the interventions. Psychiatric visits and costs were unchanged.

CONCLUSIONS

Two similar cognitive behavioral interventions, delivered with the resources available in routine primary care, improved somatization, hypochondriacal symptoms, overall psychiatric distress, and role function. They also reduced the ambulatory visits and costs of these high utilizing outpatients.
Literature
1.
go back to reference Escobar JI, Golding JM, Hough RL, Karno M, Burnham MA, Wells KB. Somatization in the community: relationship to disability and use of services. Am J Pub Health. 1987;77:837–840.CrossRef Escobar JI, Golding JM, Hough RL, Karno M, Burnham MA, Wells KB. Somatization in the community: relationship to disability and use of services. Am J Pub Health. 1987;77:837–840.CrossRef
2.
go back to reference Smith GR. The course of somatization and its effects on utilization of health care resources. Psychosomatics. 1994;35:263–267.PubMedCrossRef Smith GR. The course of somatization and its effects on utilization of health care resources. Psychosomatics. 1994;35:263–267.PubMedCrossRef
3.
go back to reference Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774–779.PubMedCrossRef Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774–779.PubMedCrossRef
4.
go back to reference Kroenke K, Spitzer RL, deGruy FV. Multisomatoform disorder. An alternative to undiffferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiat. 1997;54:352–358.PubMedCrossRef Kroenke K, Spitzer RL, deGruy FV. Multisomatoform disorder. An alternative to undiffferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiat. 1997;54:352–358.PubMedCrossRef
5.
go back to reference Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiat. 2005;62:903–910.PubMedCrossRef Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiat. 2005;62:903–910.PubMedCrossRef
6.
go back to reference Lin EH, Katon W, Von Korff M, et al. Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Int Med. 1991;6:241–246.CrossRef Lin EH, Katon W, Von Korff M, et al. Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Int Med. 1991;6:241–246.CrossRef
7.
go back to reference Barsky AJ, Wyshak G, Latham KS, Klerman GL. Hypochondriacal patients, their physicians, and their medical care. J Gen Int Med. 1991;6:413–419.CrossRef Barsky AJ, Wyshak G, Latham KS, Klerman GL. Hypochondriacal patients, their physicians, and their medical care. J Gen Int Med. 1991;6:413–419.CrossRef
8.
go back to reference Hahn SR, Kroenke K, Spitzer RL, et al. The difficult patient in primary care: prevalence, psychopathology, and impairment. J Gen Int Med. 1996;11:1–8.CrossRef Hahn SR, Kroenke K, Spitzer RL, et al. The difficult patient in primary care: prevalence, psychopathology, and impairment. J Gen Int Med. 1996;11:1–8.CrossRef
9.
go back to reference Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159:1069–1075.PubMedCrossRef Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159:1069–1075.PubMedCrossRef
10.
go back to reference Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881–888.PubMedCrossRef Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881–888.PubMedCrossRef
11.
go back to reference Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007;69:889–900.PubMedCrossRef Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007;69:889–900.PubMedCrossRef
12.
go back to reference Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med. 2002;64:939–950.PubMedCrossRef Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med. 2002;64:939–950.PubMedCrossRef
13.
go back to reference Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–215.PubMedCrossRef Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–215.PubMedCrossRef
14.
go back to reference Raine R, Haines AP, Sensky T, Hutchings A, Larkin KT, Black N. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? Br Med J. 2002;325:1082.CrossRef Raine R, Haines AP, Sensky T, Hutchings A, Larkin KT, Black N. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? Br Med J. 2002;325:1082.CrossRef
15.
go back to reference Hedman E, Ljotsson B, Andersson E, Ruck C, Andersson G, Lindefors N. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial. Cogn Behav Ther. 2010;39:239–250.PubMedCrossRef Hedman E, Ljotsson B, Andersson E, Ruck C, Andersson G, Lindefors N. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial. Cogn Behav Ther. 2010;39:239–250.PubMedCrossRef
16.
go back to reference Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis. Br J Psychiat. 1998;173:218–225.CrossRef Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis. Br J Psychiat. 1998;173:218–225.CrossRef
17.
go back to reference Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis; A randomized controlled trial. JAMA. 2004;291:1464–1470.PubMedCrossRef Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis; A randomized controlled trial. JAMA. 2004;291:1464–1470.PubMedCrossRef
18.
go back to reference Sumathipala A, Hewege S, Hanwella R, Mann AH. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychol Med. 2000;30:747–757.PubMedCrossRef Sumathipala A, Hewege S, Hanwella R, Mann AH. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychol Med. 2000;30:747–757.PubMedCrossRef
19.
go back to reference Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006;166:1512–1518.PubMedCrossRef Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006;166:1512–1518.PubMedCrossRef
20.
go back to reference Hellman CJC, Budd M, Borysenko J, McClelland DC, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med. 1990;16:165–173.PubMedCrossRef Hellman CJC, Budd M, Borysenko J, McClelland DC, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med. 1990;16:165–173.PubMedCrossRef
21.
go back to reference Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M. Explanatory therapy in hypochondriasis. J Clin Psychiatry. 2000;61:317–322.PubMedCrossRef Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M. Explanatory therapy in hypochondriasis. J Clin Psychiatry. 2000;61:317–322.PubMedCrossRef
22.
go back to reference Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164:91–99.PubMedCrossRef Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164:91–99.PubMedCrossRef
23.
go back to reference Sorensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011;41:431–441.PubMedCrossRef Sorensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011;41:431–441.PubMedCrossRef
24.
go back to reference Rost K, Kashner TM, Smith GR Jr. Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs. Gen Hosp Psychiat. 1994;16:381–387.CrossRef Rost K, Kashner TM, Smith GR Jr. Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs. Gen Hosp Psychiat. 1994;16:381–387.CrossRef
25.
go back to reference Kashner TM, Rost K, Smith GR, Lewis S. An analysis of panel data; the impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder. Med Care. 1992;30:811–821.PubMedCrossRef Kashner TM, Rost K, Smith GR, Lewis S. An analysis of panel data; the impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder. Med Care. 1992;30:811–821.PubMedCrossRef
26.
go back to reference Smith GR, Rost K, Kashner TM. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Arch Gen Psychiat. 1995;52:238–243.PubMedCrossRef Smith GR, Rost K, Kashner TM. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Arch Gen Psychiat. 1995;52:238–243.PubMedCrossRef
27.
go back to reference Dickinson WP, Dickinson LM, deGruy FV, Main DS, Candib LM, Rost K. A randomized clinical trial of a care recommendation letter intervention for somatization in primary care. Ann Fam Med. 2003;1:228–235.PubMedCrossRef Dickinson WP, Dickinson LM, deGruy FV, Main DS, Candib LM, Rost K. A randomized clinical trial of a care recommendation letter intervention for somatization in primary care. Ann Fam Med. 2003;1:228–235.PubMedCrossRef
28.
go back to reference Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med. 2006;21:671–677.PubMedCrossRef Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med. 2006;21:671–677.PubMedCrossRef
29.
go back to reference Rief W, Martin A, Rauh E, Zech T, Bender A. Evaluation of general practitioners’ training: how to manage patients with unexplained physical symptoms. Psychosomatics. 2006;47:304–311.PubMedCrossRef Rief W, Martin A, Rauh E, Zech T, Bender A. Evaluation of general practitioners’ training: how to manage patients with unexplained physical symptoms. Psychosomatics. 2006;47:304–311.PubMedCrossRef
30.
go back to reference Sharpe M, Carson A. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med. 2001;134:926–930.PubMedCrossRef Sharpe M, Carson A. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med. 2001;134:926–930.PubMedCrossRef
31.
go back to reference Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86:262–266.PubMedCrossRef Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86:262–266.PubMedCrossRef
32.
go back to reference Speckens AEM, van Hemert AM, Bolk JH, Rooijmans HGM, Hengeveld MW. Unexplained physical symptoms: outcome, utilization of medical care and associated factors. Psychol Med. 1996;26:745–752.PubMedCrossRef Speckens AEM, van Hemert AM, Bolk JH, Rooijmans HGM, Hengeveld MW. Unexplained physical symptoms: outcome, utilization of medical care and associated factors. Psychol Med. 1996;26:745–752.PubMedCrossRef
33.
go back to reference Jackson JL, Kroenke K. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70:430–434.PubMedCrossRef Jackson JL, Kroenke K. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70:430–434.PubMedCrossRef
34.
go back to reference Speckens AEM, van Hemert A, Bolk JH, Hawton KE, Rooijmans HGM. The acceptability of psychological treatment in patients with medically unexplained physical symptoms. J Psychosom Res. 1995;7:855–863.CrossRef Speckens AEM, van Hemert A, Bolk JH, Hawton KE, Rooijmans HGM. The acceptability of psychological treatment in patients with medically unexplained physical symptoms. J Psychosom Res. 1995;7:855–863.CrossRef
35.
go back to reference Benjamin S, Bridges K. The special needs of chronic somatizers. In: Benjamin S, House A, Jenkins P, eds. Liaison psychiatry: defining needs and planning services. London: Gaskell Press, Royal Collage of Psychiatrists; 1994:16–23. Benjamin S, Bridges K. The special needs of chronic somatizers. In: Benjamin S, House A, Jenkins P, eds. Liaison psychiatry: defining needs and planning services. London: Gaskell Press, Royal Collage of Psychiatrists; 1994:16–23.
36.
go back to reference Bass CM. Assessment and management of patients with functional somatic symptoms. In: Bass CM, ed. Somatization: physical symptoms and psychological illness. Oxford: Blackwell; 1990:40–72. Bass CM. Assessment and management of patients with functional somatic symptoms. In: Bass CM, ed. Somatization: physical symptoms and psychological illness. Oxford: Blackwell; 1990:40–72.
37.
go back to reference Barsky AJ, Fama JM, Bailey ED, Ahern DK. A prospective 4–5 year study of DSM-III-R hypochondriasis. Arch Gen Psychiat. 1998;55:737–744.PubMedCrossRef Barsky AJ, Fama JM, Bailey ED, Ahern DK. A prospective 4–5 year study of DSM-III-R hypochondriasis. Arch Gen Psychiat. 1998;55:737–744.PubMedCrossRef
38.
39.
go back to reference Johnson C, Shenoy RS, Langer S. Relaxation therapy for somatoform disorders. Hosp Commun Psychiat. 1981;32:423–424. Johnson C, Shenoy RS, Langer S. Relaxation therapy for somatoform disorders. Hosp Commun Psychiat. 1981;32:423–424.
40.
go back to reference Jacobsen E. Progressive relaxation: a physiological and clinical investigation of muscular states and their significance in psychology and medical practice. Chicago: University of Chicago Press; 1974. Jacobsen E. Progressive relaxation: a physiological and clinical investigation of muscular states and their significance in psychology and medical practice. Chicago: University of Chicago Press; 1974.
41.
go back to reference Weinstein MC, Berwick DM, Goldman PA, Murphy JM, Barsky AJ. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care. 1989;27:593–607.PubMedCrossRef Weinstein MC, Berwick DM, Goldman PA, Murphy JM, Barsky AJ. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care. 1989;27:593–607.PubMedCrossRef
42.
go back to reference Barsky AJ, Wyshak G, Klerman GL. Hypochondriasis: an evaluation of the DSM-III criteria in medical outpatients. Arch Gen Psychiat. 1986;43:493–500.PubMedCrossRef Barsky AJ, Wyshak G, Klerman GL. Hypochondriasis: an evaluation of the DSM-III criteria in medical outpatients. Arch Gen Psychiat. 1986;43:493–500.PubMedCrossRef
43.
go back to reference Barsky AJ, Wyshak G, Klerman GL. Medical and psychiatric determinants of outpatient medical utilization. Med Care. 1986;24:548–560.PubMedCrossRef Barsky AJ, Wyshak G, Klerman GL. Medical and psychiatric determinants of outpatient medical utilization. Med Care. 1986;24:548–560.PubMedCrossRef
44.
go back to reference Barsky AJ, Cleary PD, Spitzer RL, Williams JBW, Wyshak G, Klerman GL. A structured diagnostic interview for hypochondriasis: a proposed criterion standard. J Nerv Ment Dis. 1992;180:20–27.PubMedCrossRef Barsky AJ, Cleary PD, Spitzer RL, Williams JBW, Wyshak G, Klerman GL. A structured diagnostic interview for hypochondriasis: a proposed criterion standard. J Nerv Ment Dis. 1992;180:20–27.PubMedCrossRef
45.
go back to reference Pilowsky I. A general classification of abnormal illness behaviours. Br J Med Psychol. 1978;51:131–137.PubMedCrossRef Pilowsky I. A general classification of abnormal illness behaviours. Br J Med Psychol. 1978;51:131–137.PubMedCrossRef
46.
go back to reference Pilowsky I. Dimensions of hypochondriasis. Br J Psychiat. 1967;113:89–93.CrossRef Pilowsky I. Dimensions of hypochondriasis. Br J Psychiat. 1967;113:89–93.CrossRef
47.
go back to reference Salkovskis PM, Rimes KA, Warwick HMC, Clark DM. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843–853.PubMedCrossRef Salkovskis PM, Rimes KA, Warwick HMC, Clark DM. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843–853.PubMedCrossRef
48.
go back to reference Deacon B, Abramowitz JS. Is hypochondriasis related to obsessive-compulsive disorder, panic disorder, or both? An empirical evaluation. J Cog Psychother. 2008;22:115–127.CrossRef Deacon B, Abramowitz JS. Is hypochondriasis related to obsessive-compulsive disorder, panic disorder, or both? An empirical evaluation. J Cog Psychother. 2008;22:115–127.CrossRef
49.
go back to reference Jette AM, Davies AR, Cleary PD, et al. The functional status questionnaire: reliability and validity when used in primary care. J Gen Int Med. 1986;1:143–149.CrossRef Jette AM, Davies AR, Cleary PD, et al. The functional status questionnaire: reliability and validity when used in primary care. J Gen Int Med. 1986;1:143–149.CrossRef
50.
go back to reference Cleary PD, Jette AJ. Reliability and validity of the functional status questionnaire. Qual Life Res. 2001;9:747–753.CrossRef Cleary PD, Jette AJ. Reliability and validity of the functional status questionnaire. Qual Life Res. 2001;9:747–753.CrossRef
51.
go back to reference Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1–15.PubMedCrossRef Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1–15.PubMedCrossRef
52.
go back to reference Derogatis LR. SCL-90. Administration, scoring and procedures manual. Clinical psychometric research. Baltimore: John Hopkins University School of Medicine; 1977. Derogatis LR. SCL-90. Administration, scoring and procedures manual. Clinical psychometric research. Baltimore: John Hopkins University School of Medicine; 1977.
53.
go back to reference Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL): factors derived from the HSCL-90. Psychopharm Bull. 1977;13:43–45. Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL): factors derived from the HSCL-90. Psychopharm Bull. 1977;13:43–45.
54.
go back to reference Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57:35–43.PubMedCrossRef Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57:35–43.PubMedCrossRef
56.
go back to reference Esch T, Fricchione GL, Stefano GB. The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit. 2003;9:RA23–RA34.PubMed Esch T, Fricchione GL, Stefano GB. The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit. 2003;9:RA23–RA34.PubMed
57.
go back to reference Barsky AJ, Cleary PD, Sarnie MK, Klerman GL. The course of transient hypochondriasis. Am J Psychiat. 1993;150:484–488.PubMed Barsky AJ, Cleary PD, Sarnie MK, Klerman GL. The course of transient hypochondriasis. Am J Psychiat. 1993;150:484–488.PubMed
Metadata
Title
A Randomized Trial of Treatments for High-Utilizing Somatizing Patients
Authors
Arthur J. Barsky, MD
David K. Ahern, PhD
Mark R. Bauer, MD
Nyryan Nolido, MA
E. John Orav, PhD
Publication date
01-11-2013
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2392-6

Other articles of this Issue 11/2013

Journal of General Internal Medicine 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.